Neuropsychological Evaluations in Limbic Encephalitis.
assessment
auto-antibodies
autoimmune epilepsy
behavior
cognition
diagnostics
limbic encephalitis
memory
monitoring
neuropsychology
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
29 Apr 2021
29 Apr 2021
Historique:
received:
12
04
2021
revised:
27
04
2021
accepted:
27
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
Limbic encephalitis (LE) can cause dynamic and permanent impairment of cognition and behavior. In clinical practice, the question arises as to which cognitive and behavioral domains are affected by LE and which assessment is suited to monitor the disease progress and the success of treatment. Current findings on cognition and behavior in LE are reviewed and discussed based on current guidelines and consensus papers. In addition, we outline approaches for the neuropsychological monitoring of LE and its treatment. Dependent on disease acuity and severity, LE leads to episodic long-term memory dysfunction in different variants (e.g., anterograde memory impairment, accelerated long-term forgetting, and affection of autobiographical memory) and executive deficits. In addition, affective disorders are very common. More severe psychiatric symptoms may occur as well. In the course of the disease, dynamic phases with functional recovery must be differentiated from residual defect states. Evidence-based neuropsychological diagnostics should be conducted ideally before treatment initiation and reassessments are indicated when any progress is suggested, and when decisive anti-seizure or immunomodulatory treatment changes are made. Cognition and behavior may but must not run in synchrony with seizures, MRI pathology, or immune parameters. Cognitive and behavioral problems are integral aspects of LE and represent important biomarkers of disease acuity, progress, and therapy response beyond and in addition to parameters of immunology, neurological symptoms, and brain imaging. Thus, evidence-based neuropsychological assessments are essential for the diagnostic workup of patients with suspected or diagnosed limbic encephalitis, for treatment decisions, and disease and treatment monitoring.
Identifiants
pubmed: 33947002
pii: brainsci11050576
doi: 10.3390/brainsci11050576
pmc: PMC8145692
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
JAMA Neurol. 2017 Jan 1;74(1):50-59
pubmed: 27893017
Transl Psychiatry. 2020 Sep 1;10(1):304
pubmed: 32873782
J Neurol Sci. 2017 Oct 15;381:126-127
pubmed: 28991662
Brain Cogn. 1997 Oct;35(1):71-84
pubmed: 9339303
Biol Psychiatry. 2011 Aug 15;70(4):e15-7
pubmed: 21531392
Front Neurol. 2015 Jun 09;6:130
pubmed: 26106363
J Neurol. 2014 Sep;261(9):1695-705
pubmed: 24935858
Br J Psychiatry. 2006 Aug;189:182-3
pubmed: 16880491
Front Neurol. 2019 Apr 26;10:330
pubmed: 31080433
Neuroimage Clin. 2020;27:102289
pubmed: 32623136
Neuropsychologia. 1990;28(11):1221-7
pubmed: 2290496
Epilepsia. 2012 Oct;53(10):1765-73
pubmed: 22881602
Brain Cogn. 1997 Oct;35(1):110-31
pubmed: 9339305
Seizure. 2012 Mar;21(2):134-40
pubmed: 22119172
J Neuroimmunol. 2021 Feb 15;351:577471
pubmed: 33418181
J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):40-7
pubmed: 11413260
Psychoneuroendocrinology. 2005 Sep;30(8):771-84
pubmed: 15919583
Adv Neurol. 1999;81:271-9
pubmed: 10609023
Epilepsy Behav. 2010 Feb;17(2):215-20
pubmed: 20056493
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):735-42
pubmed: 25185210
Cortex. 1991 Dec;27(4):547-55
pubmed: 1782789
Epilepsia. 2016 Mar;57(3):475-83
pubmed: 26749370
Expert Opin Pharmacother. 2017 Apr;18(6):551-554
pubmed: 28303728
Clin Neuropsychol. 2007 Sep;21(5):811-25
pubmed: 17676546
Physiol Rev. 2017 Apr;97(2):839-887
pubmed: 28298428
Eur J Neurol. 2013 Sep;20(9):1297-304
pubmed: 23678940
Cortex. 2011 Apr;47(4):451-9
pubmed: 20359701
Neurology. 2020 Mar 24;94(12):e1320-e1335
pubmed: 31980582
Arch Neurol. 2007 Mar;64(3):404-10
pubmed: 17353384
Brain Struct Funct. 2019 May;224(4):1599-1607
pubmed: 30863886
J Neurol. 2021 Feb;268(2):455-466
pubmed: 32816110
Handb Clin Neurol. 2008;88:137-54
pubmed: 18631689
Nat Protoc. 2006;1(2):892-9
pubmed: 17406322
Stroke. 2005 Apr;36(4):777-81
pubmed: 15718510
Neuroscience. 2019 Feb 21;400:120-131
pubmed: 30625332
J Clin Exp Neuropsychol. 1989 Oct;11(5):724-44
pubmed: 2808661
J Clin Exp Neuropsychol. 1995 Dec;17(6):809-19
pubmed: 8847387
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Epilepsy Behav. 2021 Apr;117:107865
pubmed: 33662843
Lancet Neurol. 2004 Nov;3(11):663-72
pubmed: 15488459
Brain. 2008 Sep;131(Pt 9):2243-63
pubmed: 18669495
Curr Opin Neurol. 2021 Apr 1;34(2):166-171
pubmed: 33464762
Epilepsy Behav. 2008 Oct;13(3):535-41
pubmed: 18583196
Rehabilitation (Stuttg). 2012 Oct;51(5):289-99
pubmed: 22473480
Neuropsychologia. 2011 Mar;49(4):718-33
pubmed: 20933525
Mayo Clin Proc. 2010 Oct;85(10):881-97
pubmed: 20884824
Cortex. 2019 Jan;110:58-68
pubmed: 29475601
Acta Neurol Scand. 2017 Jan;135(1):134-141
pubmed: 26940288
J Cogn Neurosci. 2013 Jan;25(1):14-21
pubmed: 22905817
J Cogn Neurosci. 2000 Jan;12(1):1-47
pubmed: 10769304
Front Immunol. 2017 Sep 11;8:1101
pubmed: 28955334
J Neuroimmunol. 2020 Aug 15;345:577271
pubmed: 32480239
Epilepsy Behav. 2015 Nov;52(Pt A):19-24
pubmed: 26398592